AdminAmway (Malaysia) Holdings Berhad (AMWAY Malaysia) recently launched the “Gut Reset-Weight Management” educational and awareness nationwide campaign to strengthen further its efforts to address non-communicable diseases (NCDs).
With the increasing prevalence of NCDs putting additional strain on the country’s health system and an annual healthcare cost exceeding RM9.65 billion, AMWAY Malaysia aims to support Malaysia’s focus on preventive healthcare, with a special focus on weight management.
Diabetes, high cholesterol, high blood pressure, and obesity are growing health problems for many Malaysians, as evidenced by alarming statistics. According to the National Health and Morbidity Survey (NHMS) 2019, an estimated 1.7 million Malaysians have three major risk factors for cardiovascular disease, while 3.4 million Malaysians have two major risk factors.
In addition, the NHMS found that about one in five adults Malaysians live with diabetes, one in three with hypertension, two with high cholesterol and nearly half are overweight or obese.
AMWAY Malaysia’s Managing Director, Mr Michael Jonathan Duong, said, “In response to our government’s strategy to support the fight against non-communicable diseases, AMWAY, as a leading health and wellness company, recognizes the critical role of the private sector in addressing our national health concerns. With this in mind, AMWAY Malaysia is stepping up efforts to provide healthier lifestyle products and solutions through the “Gut Reset-Weight Management” educational and awareness campaign, with the aim of encouraging Malaysians to adopt a healthy lifestyle to avoid the risks of non-communicable diseases.”
Gut Reset-Weight Management
The launch of the “Gut Reset-Weight Management” campaign forms an important milestone for the health and wellness company this year, further strengthening Nutrilite’s market position globally for nearly 90 years. Nutrilite is AMWAY’s flagship brand which offers a range of nutritional and dietary supplements that help improve overall wellness.
The campaign has a core focus on a healthy gut, as it is a critical precursor to a healthy weight in the long term. The campaign will include a personalized weight and nutritional needs management programme encompassing a balanced diet, supplements, exercise and a holistic lifestyle change.
It aims to provide essential daily nutrients, and fibre one needs for overall weight control. In addition, the programme offers individual health screening through an exclusive partnership with Innoquest Pathology, a leading diagnostic company in Malaysia, for over 30 years.
Tackling NCDs is one of AMWAY Malaysia’s key thrusts within its 6 Pillars of Focus for 2023, referred to as the “BIG HEALTH” initiative.
Supporting Amway Business Owners
AMWAY Malaysia’s second focus for 2023 is to build a more sustainable entrepreneurship model to support Amway Business Owners (ABOs), which will drive the Group’s business growth.
“We strive to support our Amway Business Owners in their entrepreneurial journey towards generating sustainable income and creating value through mutually beneficial partnerships by helping them discover their full potential and achieve their goals. With over 400,000 ABOs within our network, we continuously focus on ABO-centric programmes and incentives, as we journey together towards AMWAY Malaysia’s 50th anniversary vision to be one of the leading health and wellness companies in Malaysia by 2026,” Duong said.
AMWAY Malaysia registered a new record revenue of RM1,514.8 million in the financial year ended December 31, 2022 (FY2022), up 1.9% from RM1,485.9 million recorded in the previous financial year. The increase in sales was mainly due to strong demand for health and wellness and personal care products under the Lead with Nutrition initiative.
Meanwhile, its net profit recorded a stellar growth of 109% to RM76.88 million compared to RM36.78 million registered in FY2021.
